(Press-News.org) To make cancer care smoother and more effective, the Alliance for Clinical Trials in Oncology has introduced a new clinical trial for people with gastrointestinal cancers, such as cancers of the stomach, colon, and esophagus. The PAGODA trial (Alliance A232402CD) will test a proactive approach to chemotherapy dose adjustments, aiming to minimize treatment interruptions and help patients complete their chemotherapy as planned.
“Unplanned chemotherapy interruptions can be stressful, time consuming, and may affect how well treatment works,” said study chair Gabriel Brooks, MD, MPH, an Associate Professor of Medicine at the Dartmouth Geisel School of Medicine. “Our trial will test a new approach that uses a clear, step-by-step plan to adjust chemotherapy doses before problems occur rather than waiting until side effects happen.”
While some treatment delays are necessary due to new or worsening medical problems, many delays are triggered by asymptomatic changes that are only found in routine blood work. These unplanned delays are disruptive for patients and their caregivers because they lead to additional travel, blood draws, clinic visits, and time away from home and work—a phenomenon increasingly recognized as time toxicity.
Unplanned delays are also inefficient for clinical teams, resulting in unused treatment capacity at the time of the delay and duplicative future clinic visits and laboratory testing. Lastly, delays that lead to reduced chemotherapy dose-intensity can have a negative effect on cancer treatment outcomes
This trial will test PAGODA, the Proactive Graduated Dose Modification Algorithm. It’s a structured plan that helps doctors make small, proactive changes to chemotherapy doses to prevent treatment delays. Instead of reacting after severe side effects occur, PAGODA guides doctors to act early, keeping patients on schedule and reducing stress and delays.
The trial plans to enroll about 400 patients with cancer of the esophagus, gastroesophageal junction, stomach, small intestine, appendix, colon, rectum, and cancers of unknown primary with suspected GI origin. Participants will be randomly assigned to one of two groups:
o Standard Care: Doctors adjust chemotherapy doses as they normally would.
o PAGODA Approach: Doctors follow the algorithm to guide dose changes.
Both groups receive the same chemotherapy drugs commonly used for GI cancers.
"This study is about improving experience for patients and their loved ones,” added Dr. Brooks. “We want to reduce the uncertainty and interruptions that come with traditional dosing methods and give patients a smoother, more predictable treatment journey. If PAGODA proves successful, it could change how we manage chemotherapy for gastrointestinal cancers—making care more consistent and less burdensome.”
# # #
Reference: Alliance A232402CD/NCT07283939 - PAGODA: Randomized Trial of a Proactive Graduated Dose Modification Algorithm for FOLFOX Chemotherapy to Prevent Unplanned Delays
The Alliance for Clinical Trials in Oncology is a national leader in advancing cancer research, uniting more than 25,000 cancer specialists at 115 main institutions and 1,400 affiliates across the U.S. and Canada. As part of the National Clinical Trials Network and a leading research base for the NCI Community Oncology Research Program, the Alliance conducts pioneering, practice-changing clinical trials that improve outcomes and reshape standards of care. Its work has led to multiple FDA approvals, influenced national guidelines, and produced hundreds of high-impact publications. More than 40,000 participants have taken part in Alliance studies, and its growing biospecimen repository now includes more than 1.5 million samples, collected over the past 30 years. Learn more at www.AllianceforClinicalTrialsinOncology.org.
END
New alliance trial seeks to reduce delays in gastrointestinal cancer treatment
2026-01-12
ELSE PRESS RELEASES FROM THIS DATE:
Discovery of a new superfluid phase in non-Hermitian quantum systems
2026-01-12
A stable "exceptional fermionic superfluid," a new quantum phase that intrinsically hosts singularities known as exceptional points, has been discovered by researchers at Institute of Science Tokyo. Their analysis of a non-Hermitian quantum model with spin depairing shows that dissipation can actively stabilize a superfluid with these singularities embedded within it. The work reveals how lattice geometry dictates the phase's stability and provides a path to realizing it in experiments with ultracold atoms.
In the quantum world, open quantum systems are those ...
Codes in the cilia: New study maps how Cilk1 and Hedgehog levels sculpt tooth architecture
2026-01-12
Changes in early tooth development can have surprisingly big effects on a person’s smile. Missing teeth, extra teeth, unusually small or large teeth, or teeth that fuse together can cause problems in appearance, chewing , and long-term oral and general health issues. Because these problems arise from intricate signaling networks that operate during tooth development, the underlying biological causes can be difficult to pinpoint, making diagnosis and prevention challenging. Scientists have uncovered many of the networks involved, but it remains challenging to fully explain how the body decides how many teeth to form—or where each ...
Chonnam National University researchers develop novel virtual sensor grid method for low-cost, yet robust, infrastructure monitoring
2026-01-12
Structural health monitoring (SHM) and condition monitoring are crucial processes that ensure reliability and safety of engineering systems in a variety of fields, including aerospace, civil engineering, and industry. These systems are often assessed using vibration-based methods, where damage is detected by analyzing changes in a structure’s vibration characteristics. Traditional methods typically employ contact-type sensors for this purpose. While effective, these methods face several limitations, including low spatial resolution, high costs, difficulties in sensor placement, and measurements that are restricted to small regions around each sensor.
Vision-based methods, where non-contact, ...
Expanded school-based program linked to lower youth tobacco use rates in California
2026-01-12
Researchers from University of California San Diego report that an expanded, school-based tobacco prevention program in California was associated with significantly lower rates of smoking and vaping among middle and high school students. The study published in the Journal of Adolescent Health on Jan. 12, 2026, evaluated the impact of California’s Tobacco-Use Prevention Education (TUPE) program following a major funding increase approved by voters in 2016.
Using data from more than 160,000 students statewide, the researchers found that students attending schools receiving TUPE funding were 20% less likely to use tobacco overall and 23% less likely to vape, compared ...
TV depictions of Hands-Only CPR are often misleading
2026-01-12
Research Highlights:
Scripted TV programs in the U.S. often inaccurately portray who is most likely to need CPR and where out-of-hospital cardiac arrests happen, according to an analysis of more than 160 TV episodes aired since 2008.
TV programs tend to focus on white people or men receiving CPR, which mirrors real-life disparities where women and Black and Latino adults are less likely than white people to receive CPR from a lay rescuer.
The analysis examined TV depictions of out-of-hospital CPR as a potential reason why there is a low prevalence of Hands-Only ...
What TV gets wrong about CPR—and why it matters for saving lives
2026-01-12
EMBARGOED FOR RELEASE UNTIL 5 A.M., ET, MONDAY, JANUARY 12, 2026
What TV Gets Wrong About CPR—and Why it Matters for Saving Lives
PITTSBURGH, Jan. 12, 2026—Scripted television often shows outdated CPR techniques for lay people, potentially fueling misconceptions that could delay bystanders’ lifesaving interventions in the crucial moments after a real-life cardiac arrest. That’s according to University of Pittsburgh School of Public Health and School of Medicine researchers in the first analysis of TV depictions of bystander CPR, published today in Circulation: Population Health and Outcomes.
In 2008, the American Heart Association (AHA) endorsed ...
New study: How weight loss benefits the health of your fat tissue
2026-01-12
It is well known that obesity typically leads to inflammation and dysfunction of fat tissue that increases the risk of developing metabolic diseases such as diabetes and cardiovascular diseases.
It is also well established that weight loss reduces the risk of developing these diseases. However, it has been unclear whether healthy fat tissue can be reestablished by weight loss. In other words, does fat tissue retain a “memory” of the obese state after weight loss?
Now, a new study led by Assistant Professor Anne Loft, Associate Professor Jesper Grud Skat ...
Astronomers surprised by mysterious shock wave around dead star
2026-01-12
Gas and dust flowing from stars can, under the right conditions, clash with a star’s surroundings and create a shock wave. Now, astronomers using the European Southern Observatory’s Very Large Telescope (ESO’s VLT) have imaged a beautiful shock wave around a dead star — a discovery that has left them puzzled. According to all known mechanisms, the small, dead star RXJ0528+2838 should not have such structure around it. This discovery, as enigmatic as it’s stunning, challenges our ...
‘Death by a thousand cuts’: Young galaxy ran out of fuel as black hole choked off supplies
2026-01-12
Astronomers have spotted one of the oldest ‘dead’ galaxies yet identified, and found that a growing supermassive black hole can slowly starve a galaxy rather than tear it apart.
The researchers, led by the University of Cambridge, used data from the James Webb Space Telescope and the Atacama Large Millimeter Array (ALMA), to study a galaxy in the early universe – about three billion years after the Big Bang.
The galaxy, called GS-10578 but nicknamed ‘Pablo’s Galaxy’ after the astronomer who first observed it in detail, is massive for such ...
Glow with the flow: Implanted 'living skin' lights up to signal health changes
2026-01-12
[TOKYO, Japan, January 2025]—Wearable health devices, such as smartwatches, have become commonplace, enabling the continuous monitoring of physiological signals at the skin’s surface. Recently, a research team in Japan has developed a biohybrid approach that works inside the body—transforming engineered skin to a visible indicator of internal biological states.
A joint research group, led by Tokyo City University and the University of Tokyo, in collaboration with RIKEN and Canon Medical Systems ...